| 000 | 01232 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517193238.0 | ||
| 264 | 0 | _c20190403 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdx548 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBiondani, P | |
| 245 | 0 | 0 |
_aSafety of an anti-PD-1 immune checkpoint inhibitor in a liver transplant recipient. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _c01 2018 |
||
| 300 |
_a286-287 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLiver Transplantation |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNivolumab _xadverse effects |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
| 700 | 1 | _aDe Martin, E | |
| 700 | 1 | _aSamuel, D | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 29 _gno. 1 _gp. 286-287 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdx548 _zAvailable from publisher's website |
| 999 |
_c27940893 _d27940893 |
||